Los Angeles
CHANGE MY LOCATION
Business
Los Angeles Examiners
Walid Nasserdeen
Los Angeles Finance Examiner
Most Recent Post
Bull/Bear Ratio: A Contrarian Indicator
Los Angeles Finance Examiner
Most Recent Post
Bull/Bear Ratio: A Contrarian Indicator
R.E. Xavier
Los Angeles Small Business Examiner
Most Recent Post
Discover Your Business Calling (from the Small Business Doctor)
Los Angeles Small Business Examiner
Most Recent Post
Discover Your Business Calling (from the Small Business Doctor)
Multimedia News
MedImmune reports it triples first quarter profits
SEE THE LATEST ON THIS STORY
547 days ago: AstraZeneca clears key hurdle in MedImmune acquisition
551 days ago: FluMist for young children put on hold
567 days ago: Gene Logic partners with pharmaceutical giant Abbott
572 days ago: States, D.C., to share $19.5M in OxyContin settlement
588 days ago: Gaithersburg’s MedImmune sold for $15.2 billion
588 days ago: Advancis closes private placement, raises $24 million
588 days ago: MedImmune commits to sale agreement
» 602 days ago: MedImmune reports it triples first quarter profits «
608 days ago: Drug companies spend record sums on lobbying
This story ranks Not ranked
Related Topics: Gaithersburg
Gaithersburg
(Map, News)
-
Gaithersburg-based MedImmune posted earnings ranging from 62 cents to 67 cents per share in the first quarter, up from 23 cents per share in first quarter 2006. Related Topics: Gaithersburg
The drug company’s estimates are preliminary and will not be finalized until May 3.
The earnings jump was attributed to improved sales of Synagis, the company’s lung infection drug.
Add a Comment
There are no comments available.
